DHR - DANAHER CORP /DE/


166.26
-0.260   -0.156%

Share volume: 5,413,120
Last Updated: 05-12-2026
Measuring And Control Equipment/Industrial Measurement Instruments & Related Products: -0.05%

PREVIOUS CLOSE
CHG
CHG%

$166.52
-0.26
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
63%
Profitability 57%
Dept financing 46%
Liquidity 48%
Performance 76%
Company vs Stock growth
vs
Performance
5 Days
-2.86%
1 Month
-15.12%
3 Months
-21.79%
6 Months
-24.84%
1 Year
-15.44%
2 Year
-33.92%
Key data
Stock price
$166.26
P/E Ratio 
34.80
DAY RANGE
$165.57 - $167.93
EPS 
$5.19
52 WEEK RANGE
$165.25 - $242.80
52 WEEK CHANGE
-$11.48
MARKET CAP 
128.360 B
YIELD 
0.75%
SHARES OUTSTANDING 
707.771 M
DIVIDEND
$0.40
EX-DIVIDEND DATE
06-26-2026
NEXT EARNINGS DATE
07-22-2025
BETA 
0.56
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$5,348,765
AVERAGE 30 VOLUME 
$5,352,812
Company detail
CEO: Rainer M. Blair
Region: US
Website: danaher.com
Employees: 81,000
IPO year: 1987
Issue type: Common Stock
Market: NYSE
Industry: Measuring And Control Equipment/Industrial Measurement Instruments & Related Products
Sector: Manufacturing

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics.

Recent news